Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457639 · ClinicalTrials.gov registry record · Phase 2
Cholic Acid for Hepatic Steatosis in Lipodystrophy
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00457639 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT00457639, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
To evaluate the efficacy and safety of cholic acid therapy in treating lipodystrophy patients with hepatic steatosis. This is a randomized, double-blind, placebo-controlled cross-over study.
Interventions
- DRUG Cholic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457639
The ClinicalTrials.gov registry entry for NCT00457639 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholic Acid is the first listed.
NCT00457639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00457639 about?
NCT00457639 is a clinical study titled "Cholic Acid for Hepatic Steatosis in Lipodystrophy". To evaluate the efficacy and safety of cholic acid therapy in treating lipodystrophy patients with hepatic steatosis. This is a randomized, double-blind, placebo-controlled cross-over study.
What is the current status of trial NCT00457639?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2006-04. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00457639?
The interventions under investigation include: Cholic Acid (DRUG).
Who is sponsoring clinical trial NCT00457639?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.